An Overview of Global Blood Therapeutics, Inc. (GBT)

General Summary of Global Blood Therapeutics, Inc. (GBT)

• Global Blood Therapeutics, Inc. (GBT) was founded in 2011 and is headquartered in South San Francisco, California.
• The company specializes in the development of novel therapies for the treatment of blood disorders.
• GBT's flagship product is Oxbryta, which was approved by the FDA in 2019 for the treatment of sickle cell disease.
• As of 2024, GBT has shown significant growth in sales, reaching a record-high in revenue.

Company's Financial Performance in the Latest Financial Reports

• GBT reported record-breaking revenue in the latest financial reports, driven by the strong sales of Oxbryta.
• The company has seen substantial growth in key markets, leading to increased market share and profitability.
• GBT's financial performance has exceeded expectations, positioning the company as a key player in the biopharmaceutical industry.

Introduction to Global Blood Therapeutics, Inc. as a Leader in the Industry

• GBT is recognized as one of the leading companies in the biopharmaceutical industry, known for its innovative therapies and strong market presence.
• The company's commitment to developing groundbreaking treatments for blood disorders has solidified its position as a key player in the industry.
• Read on to discover more about GBT's success and its impact on the healthcare landscape.

Mission Statement of Global Blood Therapeutics, Inc. (GBT)

Global Blood Therapeutics, Inc. (GBT) is a biopharmaceutical company dedicated to discovering, developing, and delivering innovative treatments for patients with blood disorders. The company's Mission Statement serves as a guiding principle in achieving its long-term goals and making a positive impact on the lives of those affected by these disorders.

Mission Statement: GBT's Mission Statement is to transform the treatment of sickle cell disease and other blood disorders through the development of novel therapeutics. By focusing on unmet medical needs and leveraging cutting-edge research and technology, GBT is committed to improving the lives of patients worldwide.

Vision: GBT envisions a future where individuals with blood disorders have access to effective and life-changing treatments that enable them to live healthier and more fulfilling lives. Through continuous innovation and collaboration with healthcare professionals, GBT strives to redefine the standard of care for these conditions.

Core Values:

• Patient-Centricity: GBT places patients at the forefront of everything it does. The company is dedicated to understanding the needs and challenges faced by individuals with blood disorders, ensuring that its therapies are tailored to improve their quality of life.
• Innovation: GBT is committed to advancing the field of blood disorder treatments through innovative research and development. By exploring new pathways and technologies, the company aims to bring groundbreaking therapies to market that address unmet medical needs.
• Integrity: GBT upholds the highest ethical standards in all aspects of its operations. The company prioritizes transparency, honesty, and accountability in its interactions with patients, healthcare providers, and stakeholders, fostering trust and credibility within the healthcare industry.

Through its unwavering dedication to its Mission Statement, Vision, and Core Values, GBT continues to make significant strides in the field of blood disorder therapeutics. The company's commitment to delivering high-quality products and services is evident in its ongoing clinical trials, partnerships with leading healthcare organizations, and advocacy for improved patient care. With a focus on innovation and patient-centricity, GBT is well-positioned to lead the way in transforming the treatment landscape for individuals with blood disorders.

Vision Statement of Global Blood Therapeutics, Inc. (GBT)

Mission Statement: Global Blood Therapeutics, Inc. (GBT) is dedicated to discovering, developing, and delivering life-changing treatments for underserved patient communities facing serious and life-threatening blood diseases. Our mission is to transform the treatment landscape for these diseases and improve the lives of patients around the world.

Vision: In 2024, GBT envisions a future where every individual living with a blood disorder has access to innovative and effective therapies that not only manage their condition but also enhance their quality of life. We strive to be a global leader in blood disease research and treatment, setting new standards for patient care and outcomes.

Core Values:

• Commitment to Patients: Our unwavering dedication to meeting the needs of patients drives everything we do at GBT. We prioritize patient well-being above all else and work tirelessly to develop therapies that address their unique challenges.
• Innovation: We embrace innovation as a cornerstone of our company, constantly seeking new ways to advance the field of blood disease treatment. By pushing the boundaries of scientific discovery, we aim to revolutionize patient care.
• Integrity: At GBT, we hold ourselves to the highest ethical standards and always act with honesty and transparency. We believe in doing what is right, even when faced with difficult decisions or challenges.
• Diversity and Inclusion: We celebrate the diverse perspectives and backgrounds of our team members, recognizing that inclusivity drives creativity and innovation. By fostering a culture of respect and collaboration, we empower every individual to contribute their unique skills to our mission.
• Collaboration: We believe in the power of collaboration and partnership to achieve our goals. By working closely with patients, healthcare providers, researchers, and other stakeholders, we strive to create a unified community dedicated to improving the lives of those affected by blood disorders.

Core Values of Global Blood Therapeutics, Inc. (GBT)

Commitment to Innovation

Global Blood Therapeutics, Inc. (GBT) has always prioritized innovation in the development of treatments for hematologic disorders. The company is committed to pushing the boundaries of medical research to bring life-changing therapies to patients in need. One of the ways GBT demonstrates this commitment is through its investment in cutting-edge research and development initiatives.

• GBT has a dedicated team of scientists and researchers who are constantly exploring new treatment modalities and technologies to address unmet medical needs in the field of hematology.
• The company has also formed strategic partnerships with leading academic institutions and biotech companies to collaborate on innovative research projects.
• GBT regularly participates in industry conferences and events to stay abreast of the latest scientific advancements and trends in the field.

Focus on Patient-Centricity

At the core of GBT's mission is a commitment to putting patients first. The company recognizes the importance of understanding the needs and challenges of individuals living with hematologic disorders and strives to develop therapies that improve their quality of life. GBT's patient-centric approach is evident in its various patient support programs and initiatives.

• The company offers comprehensive patient education and advocacy programs to empower individuals to take control of their health and well-being.
• GBT works closely with patient advocacy groups and healthcare providers to ensure that patients have access to the resources and support they need throughout their treatment journey.
• The company also conducts patient surveys and focus groups to gather feedback and insights that inform the development of new therapies tailored to patients' needs.

Commitment to Diversity and Inclusion

GBT recognizes the value of diversity and inclusion in driving innovation and fostering a culture of collaboration and respect. The company is dedicated to creating a workplace that is reflective of the diverse communities it serves and is committed to promoting diversity at all levels of the organization. GBT's commitment to diversity and inclusion is evident in its various workforce development and community engagement initiatives.

• The company has implemented diversity and inclusion training programs for employees to promote understanding and awareness of different perspectives and experiences.
• GBT partners with local community organizations to support underserved populations and promote diversity in STEM fields.
• The company also sponsors mentorship programs and scholarships for students from underrepresented backgrounds to encourage diversity in the next generation of scientific leaders.

Overall Commitment to Values

As a leader in the biopharmaceutical industry, Global Blood Therapeutics, Inc. (GBT) is steadfast in its commitment to upholding its core values of innovation, patient-centricity, and diversity and inclusion. The company's unwavering dedication to these values is evident in its research and development efforts, patient support programs, and workforce development initiatives. GBT remains at the forefront of medical innovation and continues to make a meaningful impact on the lives of patients with hematologic disorders around the world.